Plectin in Cancer: From Biomarker to Therapeutic Target
The cytolinker and scaffolding protein, plectin, has emerged as a potent driver of malignant hallmarks in many human cancers due to its involvement in various cellular activities contributing to tumorigenesis, including cancer cell proliferation, adhesion, migration, invasion, and signal transductio...
Main Authors: | Samantha M. Perez, Lindsey T. Brinton, Kimberly A. Kelly |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/9/2246 |
Similar Items
-
[<sup>99m</sup>Tc]Tc-Labeled Plectin-Targeting Peptide as a Novel SPECT Probe for Tumor Imaging
by: Jiali Gong, et al.
Published: (2022-05-01) -
A Novel Monoclonal Antibody Targeting Cancer-Specific Plectin Has Potent Antitumor Activity in Ovarian Cancer
by: Samantha M. Perez, et al.
Published: (2021-08-01) -
Plectin-Mediated Intermediate Filament Functions: Why Isoforms Matter
by: Gerhard Wiche
Published: (2021-08-01) -
Plectin plays a role in the migration and volume regulation of astrocytes: a potential biomarker of glioblastoma
by: Maja Žugec, et al.
Published: (2024-01-01) -
Plectin in the Central Nervous System and a Putative Role in Brain Astrocytes
by: Maja Potokar, et al.
Published: (2021-09-01)